ESTRO 2023: Poster “Evaluating and updating predictive models: a high-tech open platform to boost clinical translation”
ESTRO 2023 Poster RADPrecise Continue
Aquilab joins the Coexya group
We are pleased to inform you that AQUILAB has joined the COEXYA group, an independent digital leader in integration and software development in #healthcare.
Log4J vulnerability not impacting AQUILAB
Dear customer, partner
We have taken into account the vulnerability concerning the Apache Log4J library and can confirm that our solutions are not affected by this security flaw. Continue
Radiotherapy Quality Assurance (RTQA) in clinical trials
Radiotherapy Quality Assurance (RTQA) is an important topic in oncology clinical trials. Continue
Dose distribution of the brain tissue associated with cognitive functions in high-grade glioma patients
ARTIVIEW Plan Check software from AQUILAB, used to assess the dose distribution regarding the brain areas Continue
Continue to fight Cancer during COVID-19
To help radiotherapy professionals during COVID-19, our service ARTIVIEW Connect* is completely free until June 30.
RadPrecise Project
Led by DKFZ with 6 other EU partners, AQUILAB will be part of RadPrecise ERA PerMed project to achieve Personalized Radiotherapy and reduce toxicities using multiple biomarkers.
New innovation for next AQUILAB products! Continue
RCR Study Day 01.10.2019
Led by Professor George Mikhaeel, this Study Day organized by The Royal College of Radiologists, provided an update on the latest evidence for radiotherapy indications and choice of optimal techniques.
ESTRO 38 26.04.2019
ARTISCAN software now compatible with Varian Halcyon™ to manage advanced Machine QA. Demo will be available during ESTRO 38 meeting in Milan on our booth #2400.